Cargando…

Prostate cancer genes associated with TMPRSS2–ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts

BACKGROUND: Recent studies have indicated that prostate cancer patients with the TMPRSS2–ERG gene fusion have a higher risk of recurrence. To identify markers associated with TMPRSS2–ERG fusion and prognostic of biochemical recurrence, we analysed a cohort of 139 men with prostate cancer for 502 mol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barwick, B G, Abramovitz, M, Kodani, M, Moreno, C S, Nam, R, Tang, W, Bouzyk, M, Seth, A, Leyland-Jones, B
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822948/ https://www.ncbi.nlm.nih.gov/pubmed/20068566 http://dx.doi.org/10.1038/sj.bjc.6605519

Ejemplares similares

Molecular characterisation of formalin-fixed paraffin-embedded (FFPE) breast tumour specimens using a custom 512-gene breast cancer bead array-based platform
por: Abramovitz, M, et al.
Publicado: (2011)

Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer
por: Nam, R K, et al.
Publicado: (2007)

Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progression
por: Böttcher, R, et al.
Publicado: (2015)

Significance of the TMPRSS2:ERG gene fusion in prostate cancer
por: Wang, Zhu, et al.
Publicado: (2017)

Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology
por: Larzabal, L, et al.
Publicado: (2011)

TMPRSS4 regulates levels of integrin α5 in NSCLC through miR-205 activity to promote metastasis
por: Larzabal, L, et al.
Publicado: (2014)

Role of TMPRSS2-ERG Gene Fusion in Negative Regulation of PSMA Expression
por: Yin, Lihong, et al.
Publicado: (2011)

hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma
por: Lastraioli, E, et al.
Publicado: (2015)

Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort
por: Esgueva, Raquel, et al.
Publicado: (2010)

TMPRSS2-ERG fusion promotes prostate cancer metastases in bone
por: Deplus, Rachel, et al.
Publicado: (2016)

Impact TMPRSS2–ERG Molecular Subtype on Prostate Cancer Recurrence
por: Kobelyatskaya, Anastasiya A., et al.
Publicado: (2021)

Association between TMPRSS2:ERG fusion gene and the prostate cancer: systematic review and meta-analysis
por: García-Perdomo, Herney Andrés, et al.
Publicado: (2018)

Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers
por: Möller, Katharina, et al.
Publicado: (2020)

Activation of nuclear factor-κB in human prostate carcinogenesis and association to biochemical relapse
por: Domingo-Domenech, J, et al.
Publicado: (2005)

Quantitative Expression of TMPRSS2 Transcript in Prostate Tumor Cells Reflects TMPRSS2-ERG Fusion Status
por: Mwamukonda, Kuwong, et al.
Publicado: (2009)

Differential Activation of Wnt-β-Catenin Pathway in Triple Negative Breast Cancer Increases MMP7 in a PTEN Dependent Manner
por: Dey, Nandini, et al.
Publicado: (2013)

Colorimetric TMPRSS2-ERG Gene Fusion Detection in Prostate Cancer Urinary Samples via Recombinase Polymerase Amplification
por: Koo, Kevin M., et al.
Publicado: (2016)

Dual TMPRSS2:ERG Fusion in a Patient with Lung and Prostate Cancers
por: Giunchi, Francesca, et al.
Publicado: (2020)

Pyrrole-imidazole polyamide targeted to break fusion sites in TMPRSS2 and ERG gene fusion represses prostate tumor growth
por: Obinata, Daisuke, et al.
Publicado: (2014)

Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer
por: Thangapazham, Rajesh, et al.
Publicado: (2014)

Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors
por: Geybels, Milan S., et al.
Publicado: (2015)

Nuclear receptor ERRα and transcription factor ERG form a reciprocal loop in the regulation of TMPRSS2:ERG fusion gene in prostate cancer
por: Xu, Zhenyu, et al.
Publicado: (2018)

Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence
por: Truong, M, et al.
Publicado: (2012)

Androgen receptor phosphorylation at serine 515 by Cdk1 predicts biochemical relapse in prostate cancer patients
por: Willder, J M, et al.
Publicado: (2013)

A sensitive array-based assay for identifying multiple TMPRSS2:ERG fusion gene variants
por: Lu, Qing, et al.
Publicado: (2008)

Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer
por: FitzGerald, Liesel M, et al.
Publicado: (2008)

Identification of markers of prostate cancer progression using candidate gene expression
por: Larkin, S E T, et al.
Publicado: (2012)

Preliminary Results of Noninvasive Detection of TMPRSS2:ERG Gene Fusion in a Cohort of Patients With Localized Prostate Cancer
por: Tavukcu, Hasan Huseyin, et al.
Publicado: (2013)

Association of germline genetic variants with TMPRSS2-ERG fusion status in prostate cancer
por: Kohaar, Indu, et al.
Publicado: (2020)

Nifuroxazide Activates the Parthanatos to Overcome TMPRSS2:ERG Fusion-Positive Prostate Cancer
por: Li, Chengxun, et al.
Publicado: (2023)

Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progression
por: Scaggiante, B, et al.
Publicado: (2012)

Detection of oncogenic virus genomes and gene products in lung carcinoma
por: Brouchet, L, et al.
Publicado: (2005)

TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells
por: Ratz, Leonie, et al.
Publicado: (2017)

Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases
por: Teng, Y, et al.
Publicado: (2010)

Detection of human cytomegalovirus genome and gene products in central nervous system tumours
por: Sabatier, J, et al.
Publicado: (2005)

DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy
por: Paziewska, A, et al.
Publicado: (2014)

Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer
por: Kubben, F J G M, et al.
Publicado: (2006)

TMPRSS2‐ERG fusions linked to prostate cancer racial health disparities: A focus on Africa
por: Blackburn, James, et al.
Publicado: (2019)

A TMPRSS2‐ERG gene signature predicts prognosis of patients with prostate adenocarcinoma
por: Zhou, Emily, et al.
Publicado: (2020)

Celastrol Suppresses Tumor Cell Growth through Targeting an AR-ERG-NF-κB Pathway in TMPRSS2/ERG Fusion Gene Expressing Prostate Cancer
por: Shao, Longjiang, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ie9ahr2locct2nivhp54k1oigl